Jafron Biomedical Co.,Ltd.

SZSE:300529 Stock Report

Market Cap: CN¥21.0b

Jafron BiomedicalLtd Balance Sheet Health

Financial Health criteria checks 5/6

Jafron BiomedicalLtd has a total shareholder equity of CN¥3.2B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 55.5%. Its total assets and total liabilities are CN¥5.9B and CN¥2.6B respectively. Jafron BiomedicalLtd's EBIT is CN¥582.1M making its interest coverage ratio -22.2. It has cash and short-term investments of CN¥3.1B.

Key information

55.5%

Debt to equity ratio

CN¥1.80b

Debt

Interest coverage ratio-22.2x
CashCN¥3.14b
EquityCN¥3.23b
Total liabilitiesCN¥2.62b
Total assetsCN¥5.85b

Recent financial health updates

Recent updates

Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

May 28
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

May 24
A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

May 08
Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

May 02
Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Apr 13
Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Mar 22
Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Mar 04
Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Financial Position Analysis

Short Term Liabilities: 300529's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥1.2B).

Long Term Liabilities: 300529's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥1.4B).


Debt to Equity History and Analysis

Debt Level: 300529 has more cash than its total debt.

Reducing Debt: 300529's debt to equity ratio has increased from 0% to 55.5% over the past 5 years.

Debt Coverage: 300529's debt is well covered by operating cash flow (66%).

Interest Coverage: 300529 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.